EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Roflumilast attenuates neuroinflammation post retinal ischemia/reperfusion injury by regulating microglia phenotype via the Nrf2/STING/NF-κB pathway

Yuyan Guo, Chunlian Ou, Naiyuan Zhang, Qiong Liu, Ke Xiong, Jian Yu, Hao Cheng, Linjiang Chen, Ming Ma, Jing Xu, Jing Wu

International Immunopharmacology · 2023-11 · 124 · 110952

DOI: 10.1016/j.intimp.2023.110952 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023-11. Verfasst von Yuyan Guo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China; Department of Ophthalmology, The Firs…. Hauptthemen laut MEDLINE: NF-kappa B, Reperfusion Injury. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guangzhou Municipal Science and Technology Program key projects, Southern Medical University, Science and Technology Planning Project of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The abnormal polarisation of microglial cells (MGs) following retinal ischemia/reperfusion (RIR) initiates neuroinflammation and progressive death of retinal ganglion cells (RGCs), causing increasingly severe and irreversible visual dysfunction. Roflumilast (Roflu) is a promising candidate for treating neuroinflammatory diseases. This study aimed to explore whether Roflu displayed a cytoprotective effect against RIR-induced neuroinflammation and to characterise the underlying signalling pathway. METHODS: The effects and mechanism of Roflu against RIR injury were investigated in C57BL/6J mice and the BV2 cell line. We used quantitative real-time PCR and enzyme-linked immunosorbent assay to examine the levels of inflammatory factors. Furthermore, haematoxylin and eosin and immunofluorescence (IF) stainings were used to assess the morphology of the retina and the states of MGs and RGCs. Reactive oxygen species (ROS) levels were examined using a ROS assay kit, while whole-genome sequencing analysis was conducted to identify altered pathways and molecules. Western blotting and IF staining were used to quantify the proteins associated with the nuclear factor erythroid 2-related factor 2 (Nrf2)/stimulator of interferon gene (STING)/nuclear factor kappa beta (NF-κB) pathway. RESULTS: MG polarisation includes the pro-inflammatory and neurotoxic M1 phenotype as well as the anti-inflammatory and neuroprotective M2 phenotype. Roflu significantly attenuated MG activation and contributed to a shift in the MG phenotype from M1 to M2. Moreover, Roflu decreased ROS release and increased heme oxygenase 1 and NAD(P)H quinone oxidoreductase 1 expression. In vitro and in vivo experiments validated that Roflu exerted its neuroprotective effects primarily by upregulating the Nrf2/STING/NF-κB pathway. However, these effects were abrogated when the Nrf2 expression was inhibited by pharmacological or genetic manipulation. CONCLUSIONS: Roflu suppressed RIR-induced neuroinflammation by driving the shift of MG polarisation from M1 to M2 phenotype, which was mediated by the upregulation of the Nrf2/STING/NK-κB pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BReperfusion InjuryMiceAnimalsNeuroinflammatory DiseasesNF-E2-Related Factor 2MicrogliaReactive Oxygen SpeciesInflammationMice, Inbred C57BLPhenotypeRetinaIschemiaAminopyridinesBenzamidesCyclopropanes

Stichwörter der Autor:innen

Microglia cellsNeuroinflammatoryNrf2/STING/NF-κBRetina ischemia/reperfusionRoflumilast

Substanzen

NF-kappa BNF-E2-Related Factor 2Reactive Oxygen SpeciesRoflumilastAminopyridinesBenzamidesCyclopropanes

Autor:innen und Institutionen

  • Department of Ophthalmology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China; Department of Ophthalmology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 51012…
  • Department of General Practice, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China.
  • Department of Ophthalmology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China.
  • Department of Ophthalmology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, Guangdong, China.
  • Department of Ophthalmology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China. Electronic address: xjophthal@smu.edu.cn.
  • Huiqiao Medical Center, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China. Electronic address: wujingsci@126.com.

Förderung

  • Guangzhou Municipal Science and Technology Program key projects
  • Southern Medical University
  • Science and Technology Planning Project of Guangdong Province

Zitieren

APA

Guo, Y., Ou, C., Zhang, N., Liu, Q., Xiong, K., Yu, J., Cheng, H., Chen, L., Ma, M., Xu, J., & Wu, J. (2023). Roflumilast attenuates neuroinflammation post retinal ischemia/reperfusion injury by regulating microglia phenotype via the Nrf2/STING/NF-κB pathway. International Immunopharmacology, 124, 110952. https://doi.org/10.1016/j.intimp.2023.110952

Vancouver

Guo Y, Ou C, Zhang N, Liu Q, Xiong K, Yu J, et al. Roflumilast attenuates neuroinflammation post retinal ischemia/reperfusion injury by regulating microglia phenotype via the Nrf2/STING/NF-κB pathway. International Immunopharmacology. 2023;124:110952. doi:10.1016/j.intimp.2023.110952

BibTeX
@article{Guo2023,
  author = {Guo, Yuyan and Ou, Chunlian and Zhang, Naiyuan and Liu, Qiong and Xiong, Ke and Yu, Jian and Cheng, Hao and Chen, Linjiang and Ma, Ming and Xu, Jing and Wu, Jing},
  title = {Roflumilast attenuates neuroinflammation post retinal ischemia/reperfusion injury by regulating microglia phenotype via the Nrf2/STING/NF-κB pathway},
  journal = {International Immunopharmacology},
  year = {2023},
  volume = {124},
  pages = {110952},
  doi = {10.1016/j.intimp.2023.110952}
}
Kostenlos starten →